VPTDF (VentriPoint Diagnostics) Unearned Premiums

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is VentriPoint Diagnostics Unearned Premiums?

Unearned Premiums only applies to insurance companies.

VentriPoint Diagnostics Business Description

Other Exchanges VPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a Canadian medical device company that develops and commercializes diagnostic tools for monitoring patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), converts standard 2D and 3D echocardiography and MRI images into three-dimensional heart models and volumetric measurements, allowing clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. The software can be installed on standard workstations, and the company has also developed VMS+ 3D Echo and MRI applications. The company's primary customers are hospitals, cardiology clinics, and healthcare providers. VentriPoint sells its products in Canada and international markets, generating revenue through device and software sales and related licensing arrangements.